Harvard Bioscience (HBIO)
NASDAQ:HBIO
Holding HBIO?
Track your performance easily

Harvard Bioscience (HBIO) Financial Statements

184 Followers

Harvard Bioscience Financial Overview

Harvard Bioscience's market cap is currently ―. The company's EPS TTM is $-0.247; its P/E ratio is -9.72; Harvard Bioscience is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 23.10M$ 24.51M$ 25.36M$ 28.76M$ 29.98M
Gross Profit$ 13.22M$ 14.77M$ 14.73M$ 16.67M$ 18.35M
EBIT$ -3.28M$ -4.48M$ 320.00K$ -2.10M$ 1.21M
EBITDA$ -1.41M$ -2.63M$ 2.10M$ -307.00K$ 3.00M
Net Income Common Stockholders$ -2.93M$ -4.69M$ -1.24M$ -980.00K$ 58.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.05M$ 4.25M$ 5.34M$ 4.32M$ 3.79M
Total Assets$ 128.91M$ 133.16M$ 139.74M$ 142.90M$ 145.58M
Total Debt$ 40.39M$ 41.36M$ 45.29M$ 48.20M$ 51.12M
Net Debt$ 36.34M$ 37.11M$ 39.95M$ 43.88M$ 47.33M
Total Liabilities$ 61.66M$ 64.35M$ 65.45M$ 67.51M$ 71.24M
Stockholders Equity$ 67.25M$ 68.81M$ 74.29M$ 75.39M$ 74.34M
Cash Flow-
Free Cash Flow$ -1.81M$ 683.00K$ 3.96M$ 2.93M$ 1.59M
Operating Cash Flow$ -846.00K$ 1.40M$ 4.36M$ 3.55M$ 1.81M
Investing Cash Flow$ 458.00K$ -225.00K$ -401.00K$ -625.00K$ 288.00K
Financing Cash Flow$ 177.00K$ -1.05M$ -2.75M$ -2.38M$ -2.89M
Currency in USD

Harvard Bioscience Earnings and Revenue History

Harvard Bioscience Debt to Assets

Harvard Bioscience Cash Flow

Harvard Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis